Natriuretic Peptides as Cardiorenal Volume Signals

From Cardiac Stretch to a Cardiorenal Signal

A rise in cardiac filling can stretch the atria and ventricles. The heart responds in part by releasing natriuretic peptides: atrial natriuretic peptide (ANP), released predominantly by atrial cardiomyocytes, and B-type natriuretic peptide (BNP), released predominantly by ventricular cardiomyocytes in response to increased wall stress. Their effects oppose sodium and water retention: they can increase renal sodium excretion, inhibit sodium-retaining hormonal signals, and relax vascular smooth muscle.

For a quantitative systems model, the useful question is not whether a peptide is simply “high” or “low,” but how stretch changes its signal, how that signal changes renal and vascular outputs, and under what assumptions those outputs can be interpreted as changes in volume and pressure. The equations below are deliberately reduced models. They represent direction and approximate magnitude, not every physiological pathway.

A Compact Release and Signaling Model

Let \(s_A\) and \(s_V\) denote normalized atrial and ventricular stretch indices, respectively, and let \(a\) and \(b\) denote normalized circulating ANP and BNP concentrations. A simple bounded release response is \(f(s)=s/(1+s)\), for \(s\geq 0\). One possible first-order model is

Here, \(a_0\) and \(b_0\) are baseline normalized concentrations, \(a_1\) and \(b_1\) are release-response scales, and \(\tau_A\) and \(\tau_B\) are positive time constants. At a fixed stretch, the steady-state concentrations are \(a=a_0+a_1f(s_A)\) and \(b=b_0+b_1f(s_V)\). The first-order form represents production approaching a stretch-dependent target; it does not claim that secretion or clearance is literally a single process.

If \(a\) and \(b\) are scaled by their respective affinities for the shared receptor pathway, define \(x\) as their combined dimensionless effective concentration. Under a simple equilibrium binding assumption, the fraction of available receptor activation is

This expression assumes that the relevant ligand contributions can be summarized by \(x\), receptor binding equilibrates quickly relative to the modeled response, and the maximum receptor activation is normalized to one. It is a useful saturation function, not a detailed receptor-trafficking model. In particular, it does not represent all differences between ANP and BNP processing, clearance, or tissue access.

Renal Actions and Sodium Excretion

ANP and BNP can promote natriuresis through several linked processes. Their receptor-mediated cyclic GMP signaling can alter renal vascular tone and filtration, reduce tubular sodium reabsorption, and oppose renin and aldosterone signaling. The relative contribution of each route depends on physiological state and model structure. A reduced output model can represent their combined effect without claiming that all of the effect passes through one nephron segment.

For example, let \(E_{\mathrm{Na}}\) be sodium excretion in mmol/day and use the phenomenological relationship

where \(E_0\) is excretion at zero modeled peptide activation under the specified background conditions, and \(E_{\max}\) is the additional excretion at full activation. This relationship assumes that other determinants—such as sodium intake, renal function, pressure-natriuresis, and other hormones—are held fixed or absorbed into the fitted parameters. It is a local, illustrative response function, not a universal excretion law.

If \(E_{\max}>0\), then \(dE_{\mathrm{Na}}/dx=E_{\max}/(1+x)^2>0\). Thus, within this model and with the background held fixed, increasing effective peptide signal increases predicted sodium excretion. The saturation is also explicit: as \(x\) becomes large, \(\theta\) approaches one and the modeled excretion approaches \(E_0+E_{\max}\), rather than increasing without bound.

Vascular Effects and Pressure Predictions

Natriuretic-peptide signaling can relax vascular smooth muscle and lower systemic vascular resistance. To isolate this direct route, suppose cardiac output (CO) and central venous pressure (CVP) are fixed over the comparison. In a lumped circulation, mean arterial pressure (MAP) is approximated by \(MAP=CVP+CO\,R_{\mathrm{sys}}\), where \(R_{\mathrm{sys}}\) is systemic vascular resistance. A simple signal-dependent resistance is

where \(R_0\) is resistance without the modeled peptide effect and \(0\leq\gamma\leq 1\) is the maximum fractional reduction in this simplified formulation. The model requires \(1-\gamma\theta\geq 0\). It omits changes in cardiac output, reflex responses, and the renal contribution to pressure.

Interpreting Changes in Volume and Pressure

An increase in peptide signaling can affect pressure by at least two routes in this reduced picture. First, vascular relaxation can lower resistance directly. Second, increased renal sodium excretion can contribute to a decline in body sodium and extracellular volume over time if excretion exceeds intake. A lower effective circulating volume may then influence venous return, cardiac output, and pressure. These routes operate on different time scales and can be modified by compensatory responses.

Accordingly, the sign of a short-term direct vascular effect is easier to infer from the resistance equation than the size or timing of a long-term MAP change. Likewise, greater sodium excretion during a time interval does not alone establish a final volume or pressure. The interpretation requires comparing excretion with intake and considering how filtration, tubular transport, hormonal signals, and hemodynamics adapt.

Assumptions, Diagnostics, and Alternatives

The model is most defensible when stretch lies within the range used to define its response, the normalized peptide signal is nonnegative, the receptor activation function is appropriate for the intended time scale, and the renal and vascular parameters are calibrated for the background condition being studied. Fixed-background calculations are useful for isolating a pathway, but they should not be mistaken for a closed-loop prediction. Changes in kidney function, receptor responsiveness, or other hormonal inputs can change the response.

Several checks help identify a faulty or overextended model. Confirm that higher stretch produces a nondecreasing release target, that \(\theta\) remains between zero and one, that increasing \(\theta\) increases sodium excretion when \(E_{\max}>0\), and that the resistance expression remains nonnegative. Simulated concentrations or outputs that diverge despite fixed inputs may indicate a sign error, an incorrectly specified clearance term, or an unstable implementation. Compare predictions with plausible ranges for the intended application; a mathematically bounded response is not automatically physiologically calibrated.

The receptor-occupancy model is a compact alternative to separate ANP and BNP receptor-binding, processing, and clearance equations. The direct renal response is a compact alternative to explicitly representing filtration, segmental tubular transport, and hormonal suppression. These reduced forms require fewer parameters and make pathway direction transparent, but they cannot identify which mechanism generated an observed change. More detailed models are preferable when data distinguish the mechanisms or when the question concerns timing, tissue-specific effects, or altered renal function.

Common mistake: “The model predicts sodium excretion is higher, so extracellular volume and MAP must immediately fall by a calculable amount.” This confuses an excretion rate with a net balance and a pathway-specific response with a closed-loop outcome. The correction is to state what was held fixed, compare excretion with intake over time before inferring a volume trend, and account for vascular, cardiac, renal, and hormonal feedbacks before claiming a total pressure response.